MIM
NVO

Manitou Investment Management’s Novo Nordisk NVO Stock Holding History

Manitou Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8K Sell
643
-516
-45% -$22.2K 0.01% 37
2026
Q1 		$42.6K Hold
1,159
– – 0.01% 35
2025
Q4 		$59K Hold
1,159
– – 0.01% 31
2025
Q3 		$64.3K Hold
1,159
– – 0.01% 32
2025
Q2 		$80K Hold
1,159
– – 0.02% 29
2025
Q1 		$80.5K Hold
1,159
– – 0.02% 30
2024
Q4 		$99.7K Hold
1,159
– – 0.02% 26
2024
Q3 		$138K Hold
1,159
– – 0.03% 25
2024
Q2 		$165K Sell
1,159
-157
-12% -$20.8K 0.04% 26
2024
Q1 		$169K Hold
1,316
– – 0.03% 25
2023
Q4 		$136K Hold
1,316
– – 0.03% 26
2023
Q3 		$120K Hold
1,316
– – 0.03% 27
2023
Q2 		$106K Hold
1,316
– – 0.03% 27
2023
Q1 		$105K Buy
+1,316
New +$93.3K 0.03% 29

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Manitou Investment Management's NVO Position: Q2 2026 in Review

Manitou Investment Management reduced its Novo Nordisk (NVO) stake by 45% in Q2 2026, selling an estimated $22.2K and leaving 643 shares worth $30.8K. The position accounts for 0.01% of the portfolio, ranked #37.

Manitou Investment Management first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $169K in Q1 2024. 478 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Manitou Investment Management held 643 shares of Novo Nordisk worth $30.8K as of Q2 2026.
  • Manitou Investment Management sold 516 Novo Nordisk shares in Q2 2026, an estimated $22.2K.
  • Novo Nordisk made up 0.01% of Manitou Investment Management's portfolio in Q2 2026, its #37 holding.
  • Manitou Investment Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Manitou Investment Management's Novo Nordisk position peaked at $169K in Q1 2024.
  • 478 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Manitou Investment Management's 13F filing for Q2 2026, filed 7 Jul 2026.